Didn't even know there was one.
The original always scared the s*** out of me, but I'm not sure if it works on the younger generations.
However the atmosphere is the most important thing when you're watching a horror film. It's got to be at night with the lights out with a decent sound system.
@StevenBartlett@Trevornoah Bill Burr made the same point about Steve Jobs.
None of these billionaires are doing everything on their own. It would be impossible.
@PleistosceneLyf Apparently. Talking to Grok about my tweets was probably the worst thing to do as it tends to criticize them and undermine my self confidence.
I then realised I had told Grok to be a hard nosed bastard, so I guess I'm my own worst enemy. 😄
@aapakari Fundamentals are always going to be important.
They are the force multiplier that also staves off brain rot.
So don't criticise that one dude who wants to study CSS. He's going to be way better at prompting 😂
Is consistency really that important though?
I see beloved accounts take a month off and then get massive engagement when they return.
I'm not saying you should do that if you're in a growth phase, but this constant message we hear that you need to be consistent all the time ignores all the other priorities people have in their lives.
@heyclairelin That's not a good strategy because each additional post per day gets less of a push from the algorithm.
I saw somebody with 60,000 followers say to follow this advice:
• 5 posts per day
• 1 article per day
• 50 comments per day
BREAKING STUDY: Nattokinase Breaks Down SPIKE PROTEIN, AMYLOID MICROCLOTS, BLOOD CLOTS, and SHRINKS ARTERIAL PLAQUE
We assembled DECADES of evidence to uncover the powerful MULTI-TARGET EFFECTS of nattokinase:
- Degrades spike protein
- Breaks down harmful amyloid proteins
- Dissolves abnormal amyloid microclots
- Breaks down fibrin blood clots
- Boosts the body’s natural clot-dissolving system
- Shrinks arterial plaque
- Lowers blood pressure
- Reduces blood-clotting factors and platelet clumping
Our new paper, “Proteolytic Targets and Clinical Benefits of Oral Nattokinase: Spike Protein and Amyloid Degradation, Fibrinolysis, and Cardiovascular Risk Reduction,” was produced through a collaboration between The Wellness Company and the McCullough Foundation.
It represents one of the most comprehensive evaluations of nattokinase to date, uniquely integrating its proteolytic, cardiovascular, pharmacokinetic, amyloid, and spike-protein literature into a single paper.
After oral dosing, nattokinase-related activity shows up in human blood and changes clotting and clot-breakdown markers within hours.
Three independent labs have now shown that nattokinase-related enzymes can BREAK DOWN SPIKE PROTEIN in vitro—including purified nattokinase itself.
At higher doses, human imaging studies reported about a 36% SHRINKAGE in carotid artery plaque—suggesting the effective range may begin around 6,000 FU/day.
Randomized human trials also show modest BLOOD-PRESSURE reductions with nattokinase, with pooled decreases of about 3.5 mmHg systolic and 2.3 mmHg diastolic.
And in long-term population studies, higher natto intake was associated with a 25% LOWER RISK of cardiovascular death and a 32% LOWER RISK of stroke death.
Nattokinase has been well tolerated across human studies, with no notable adverse events reported across six randomized trials. Even 10,800 FU/day for 12 months was used in a large observational cohort without reported excess bleeding.
This inexpensive, orally available enzyme holds immense promise for cardiovascular risk reduction in the post-COVID era.
It now deserves large-scale clinical testing for cardiovascular risk reduction and other post-vaccination injury applications.
We plan to launch some of these studies shortly.
@twc_health@McCulloughFund@P_McCulloughMD@DrHarveyRisch@DrKellyVictory@jathorpmfm@drdrew@PeterGillooly